Efficacy and safety of antiangiogenic agents combined with HIFU in the treatment of advanced liver cancer
Antiangiogenic agents combined with HIFU are effective and safe in the treatment of advanced primary and secondary liver cancer.
Authors
- Feng Sun (ORCID: https://orcid.org/0000-0003-4842-6679)
- Lingli Fan
- Rong Wu (ORCID: https://orcid.org/0000-0002-4506-3764)
- Yu He (ORCID: https://orcid.org/0009-0006-1849-1698)
- Gang Feng (ORCID: https://orcid.org/0000-0001-8508-8416)
- Dongbiao Liao
- Yuxi Bai
- Peiyang Mao (ORCID: https://orcid.org/0009-0006-2814-0584)
- Yao Liao
- Qiuling Shi (ORCID: https://orcid.org/0000-0003-0660-3809)
Institutions
- Mianyang Central Hospital (CN)
- Chongqing Public Health Medical Center (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.3389/fonc.2025.1652434
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00